Shenzhen Neptunus Bioengineering Co., Ltd.
|
32.3 Billion CNY
|
91.095%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.39 Billion CNY
|
34.489%
|
Dong-E-E-Jiao Co.,Ltd.
|
13.3 Billion CNY
|
78.38%
|
Livzon Pharmaceutical Group Inc.
|
25.04 Billion CNY
|
88.513%
|
Hainan Haiyao Co., Ltd.
|
7.36 Billion CNY
|
60.948%
|
Tus-Pharmaceutical Group Co., Ltd.
|
1.15 Billion CNY
|
-149.911%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
32.26 Billion CNY
|
91.084%
|
Changchun High-Tech Industries (Group) Inc.
|
30.74 Billion CNY
|
90.643%
|
Apeloa Pharmaceutical Co.,Ltd
|
12.76 Billion CNY
|
77.468%
|
PKU HealthCare Corp.,Ltd.
|
2.43 Billion CNY
|
-17.984%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
2.13 Billion CNY
|
-34.84%
|
Dezhan Healthcare Company Limited
|
5.37 Billion CNY
|
46.514%
|
Jinling Pharmaceutical Company Limited
|
4.55 Billion CNY
|
36.781%
|
Jiuzhitang Co., Ltd.
|
5.32 Billion CNY
|
46.025%
|
Huapont Life Sciences Co., Ltd.
|
30.72 Billion CNY
|
90.638%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
7.98 Billion CNY
|
63.98%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
1.14 Billion CNY
|
-151.311%
|
Hengkang Medical Group Co., Ltd.
|
6.08 Billion CNY
|
52.686%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
6.45 Billion CNY
|
55.458%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
2.34 Billion CNY
|
-22.565%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
19.2 Billion CNY
|
85.019%
|
Jinhe Biotechnology CO., LTD.
|
5.45 Billion CNY
|
47.252%
|
Teyi Pharmaceutical Group Co.,Ltd
|
2.51 Billion CNY
|
-14.492%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
631.63 Million CNY
|
-355.45%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
3.52 Billion CNY
|
18.363%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
8.52 Billion CNY
|
66.273%
|
Anhui Huangshan Capsule Co., Ltd.
|
1.1 Billion CNY
|
-160.794%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
2.12 Billion CNY
|
-35.377%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
2.22 Billion CNY
|
-29.132%
|
Huaren Pharmaceutical Co., Ltd.
|
5.16 Billion CNY
|
44.31%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
6.59 Billion CNY
|
56.386%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
6.18 Billion CNY
|
53.454%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
5.97 Billion CNY
|
51.861%
|
Hybio Pharmaceutical Co., Ltd.
|
3.27 Billion CNY
|
12.218%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
2.74 Billion CNY
|
-4.915%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
5.47 Billion CNY
|
47.495%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
16.512%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
5.26 Billion CNY
|
45.315%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
1.61 Billion CNY
|
-78.186%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
3.62 Billion CNY
|
20.579%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
930.4 Million CNY
|
-209.196%
|
Hainan Poly Pharm. Co., Ltd
|
6.28 Billion CNY
|
54.24%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
3.22 Billion CNY
|
10.699%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
2.97 Billion CNY
|
3.18%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8.35 Billion CNY
|
65.565%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
6.33 Billion CNY
|
54.612%
|
PharmaBlock Sciences (Nanjing), Inc.
|
5.1 Billion CNY
|
43.637%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
3.18 Billion CNY
|
9.678%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
7.52 Billion CNY
|
61.745%
|
Betta Pharmaceuticals Co., Ltd.
|
9.14 Billion CNY
|
68.549%
|
Tibet AIM Pharm. Inc.
|
927.74 Million CNY
|
-210.083%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
15.08 Billion CNY
|
80.93%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
5.19 Billion CNY
|
44.659%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
8.63 Billion CNY
|
66.667%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
3.01 Billion CNY
|
4.742%
|
Xiamen Kingdomway Group Company
|
5.35 Billion CNY
|
46.263%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
1.43 Billion CNY
|
-100.742%
|
Walvax Biotechnology Co., Ltd.
|
15.58 Billion CNY
|
81.546%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
6.88 Billion CNY
|
58.198%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
3.15 Billion CNY
|
8.745%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
40.14 Billion CNY
|
92.835%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
2.33 Billion CNY
|
-23.124%
|
Changzhou Qianhong Biopharma CO.,LTD
|
2.76 Billion CNY
|
-4.002%
|
Honz Pharmaceutical Co., Ltd.
|
2.16 Billion CNY
|
-32.838%
|
Northeast Pharmaceutical Group Co., Ltd.
|
15.27 Billion CNY
|
81.165%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
4.52 Billion CNY
|
36.359%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
9.24 Billion CNY
|
68.883%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
5.78 Billion CNY
|
50.234%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
1.42 Billion CNY
|
-101.262%
|
Zhejiang NHU Company Ltd.
|
39.15 Billion CNY
|
92.653%
|
ApicHope Pharmaceutical Co., Ltd
|
4.4 Billion CNY
|
34.697%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
4.57 Billion CNY
|
37.184%
|
Beijing SL Pharmaceutical Co., Ltd.
|
6.27 Billion CNY
|
54.175%
|
Yunnan Baiyao Group Co.,Ltd
|
53.78 Billion CNY
|
94.651%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.33 Billion CNY
|
-115.223%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
1.54 Billion CNY
|
-86.476%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
855.53 Million CNY
|
-236.255%
|
Huadong Medicine Co., Ltd
|
33.5 Billion CNY
|
91.415%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
7.32 Billion CNY
|
60.744%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
3.44 Billion CNY
|
16.445%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
2.52 Billion CNY
|
-13.792%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
11.83 Billion CNY
|
75.693%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
2.81 Billion CNY
|
-2.034%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
1.41 Billion CNY
|
-102.748%
|
Renhe Pharmacy Co., Ltd.
|
7.44 Billion CNY
|
61.358%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
1.85 Billion CNY
|
-55.379%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
6.99 Billion CNY
|
58.861%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
5.11 Billion CNY
|
43.784%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
7.34 Billion CNY
|
60.855%
|